Almirall Expands Pipeline with Allergan’s US Dermatology Portfolio in US$650 M Deal
By Michelle Liu
Pharma Deals Review: Vol 2018 Issue 8 (Table of Contents)
Published: 16 Aug-2018
DOI: 10.3833/pdr.v2018.i8.2348 ISSN: 1756-7874
Section: Mergers & Acquisitions
Fulltext:
Abstract
Following a strategic review of the business, Allergan has agreed to sell five of its dermatology brands to Almirall in a transaction worth up to US$650 M...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS